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Determining intrafractional prostate motion
using four dimensional ultrasound system
Mariwan Baker1,2,3* and Claus F. Behrens1
Abstract
Background: In prostate radiotherapy, it is essential that the prostate position is within the planned volume during
the treatment delivery. The aim of this study is to investigate whether intrafractional motion of the prostate is of
clinical consequence, using a novel 4D autoscan ultrasound probe.
Methods: Ten prostate patients were ultrasound (US) scanned at the time of CT imaging and once a week during
their course of radiotherapy treatment in an ethics-approved study, using the transperineal Clarity autoscan system
(Clarity®, Elekta Inc., Stockholm, Sweden). At each US scanning session (fraction) the prostate was monitored for 2 to
2.5 min, a typical beam-on time to deliver a RapidArc® radiotherapy fraction. The patients were instructed to remain
motionless in supine position throughout the US scans. They were also requested to comply with a bladder-filling
protocol. In total, 51 monitoring curves were acquired. Data of the prostate motion in three orthogonal directions
were analyzed. Finally, the BMI value was calculated to investigate correlation between BMI and the extent of
prostate displacement.
Results: The patients were cooperative, despite extra time for applying the TPUS scan. The mean (±1SD) of the
maximal intrafractional displacements were [mm]; I(+)/S: (0.2 ± 0.9); L(+)/R: (−0.2 ± 0.8); and A(+)/P: (−0.2 ± 1.1),
respectively. The largest displacement was 2.8 mm in the posterior direction. The percentage of fractions with
displacements larger than 2.0 mm was 4 %, 2 %, and 10 % in the IS, LR, and AP directions, respectively. The mean
of the maximal intrafractional Euclidean distance (3D vector) was 0.9 ± 0.6 mm. For 12 % of the fractions the
maximal 3D vector displacements were larger than 2.0 mm. At only two fractions (4 %) displacements larger than 3.
0 mm were observed. There was no correlation between BMI and the extent of the prostate displacement.
Conclusions: The prostate intrafractional displacement is of no clinically consequence for treatment times in the
order of 2 – 2.5 min, which is typical for a RapidArc radiotherapy fraction. However, prostate motion should be
considered for longer treatment times eg if applying conventional or IMRT radiotherapy.
Background
In external beam radiotherapy of the prostate, it is
essential that the prescribed dose is precisely delivered
to the prostate, while reducing toxicity to rectum and
bladder. This can be achieved by daily accurate positional
verification of the prostate using image-guided radiation
therapy (IGRT) [1, 2]. Since variation in prostate position
during treatment delivery (intrafractional prostate motion)
might occur, the target may be underdosed due to a
possible prostate shift [3, 4]. Bladder filling variations,
rectal volume changes, and respiratory motion are
some of the factors that might lead to intrafractional
prostate motion [5–7].
To determine the intrafractional prostate motion,
various imaging techniques have been investigated in
different studies, such as X-ray imaging, kilovoltage (kV)
3D CBCT and megavoltage (MV) imaging, Cine-MRI,
in-room CT, implanted markers and transponders, and
ultrasound [8–11]. Most of the studies are based on
acquiring pre- and post-treatment images [12, 13].
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Various techniques are developed to enable real-time
online prostate localization and monitoring, such as:
tracking implanted electromagnetic transponders (Calypso
Medical Technologies, Seattle, WA), and tracking fiducial
markers (FMs) or implanted radioactive seeds (in
Brachytherapy) using real-time X-ray imaging. Recently,
transperineal ultrasound (TPUS) autoscan (Clarity®, Elekta
Inc., Stockholm, Sweden), a non-ionizing, non-invasive
imaging modality, has been developed to allow real-time
prostate tracking [14]. Various studies have investigated
the Calypso system to determine intrafractional prostate
motion [15–19], however, to our knowledge, there is only
one study (Ballhausen et al.) using the Clarity TPUS
system [20]. In the study by Ballhausen et al. data from 6
prostate patients are investigated. Ballhausen et al. con-
cludes that “intrafraction motion of the prostate is a
random walk” and the prostate moves away from the
isocenter during treatment delivery. In the present study,
the TPUS system was utilized to determine the intrafrac-
tional motion of the prostate.
Using advanced radiotherapy techniques, such as volu-
metric modulated arc therapy (VMAT) or RapidArc®
Radiotherapy Technology, the treatment delivery time
can be significantly reduced, thus minimizing intra-
fractional prostate motion [21, 22]. In our institution,
RapidArc radiotherapy is a standard technique for
treating prostate cancer patients, and a typical beam-on
time for a treatment fraction is approximately 2.5 min.
The aim of this study is to investigate whether the
intrafractional prostate motion, during a time interval
corresponding to the beam-on time for RapidArc, is
within 2.0 mm. 2 mm is a tolerance value which is
perceived to be clinically irrelevant according to the
British Ionization Radiation Medical Exposure Regulations
2000 (IRMER 2000).
Methods
Patients
Ten prostate cancer patients, with an average age of
68 years (range 58–76 years), were US scanned in the CT
room and once a week in the treatment room utilizing the
Clarity 4D TPUS monitoring system. All post prosta-
tectomy patients were excluded. The patients received a
cumulative dose of 76 Gy in 38 fractions, 2.0 Gy per
fraction, 5 fractions per week. Table 1. comprises patient
specifics, US scans, and the treatment technique. The
TPUS scans were performed by six radiation therapy
technologists (RTTs). The study was approved by the
Danish national ethical committee, and voluntary informed
consent was obtained for each participant according
to the World Medical Association Declaration of Helsinki
(1975/2000). The patients were placed in a supine position
and instructed to remain motionless throughout the sub-
sequent scans. To ensure better image quality, the patients
were requested to comply with a moderate bladder-filling
protocol.
Clarity ultrasound system
The Clarity system consists of two mobile units (one in
the CT room and the second in the treatment room),
which are connected through a workstation/server. The
workstation was used for target delineation and retrie-
ving the prostate monitoring curves. Details of US 3D
image reconstructions and the precision of the system
are explained thoroughly in a previous study [23]. In
short, a ceiling-mounted infrared (IR) camera recognizes
the US probe by detecting the IR-reflectors affixed to
them. This is essential for determining the geographical
position of the reconstructed anatomical structures.
To enable superimposition of the reconstructed US
images from the 4D autoscan probe on the CT images,
the system was calibrated to the same coordinate system
as the CT simulation and treatment rooms. The calibra-
tion procedure was accomplished by means of a dedicated
alignment phantom provided by the vendor.
CT room
All patients underwent a treatment planning CT scan
followed by an MRI scan. After the CT-scan the 3D-TPUS
scan was acquired. The patient was instructed to remain
Table 1 Patients characteristics, ultrasound scans, and treatment
technique
Age (Y)
Mean 68
Range 58–76
BMI
Mean 27
Range 22–37
PSA level, ng/mL
Mean 12.4
Range 2–22
Differentiation (Gleason Score)
Mean 5.7
Range 2.4–8.8
Fractions
Total fractions 38
Dose/fraction [Gy] 2.0
Race/ ethnicity Danish patients
Prostate patients Excluding all post prostatectomy
Radiation treatment Only external radiotherapy (RapidArc)
Bladder filling A standard bladder filling protocol
Number of US scans/patient 4–6 scans
Total number of US scans 51 scans
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still during image acquisition and US monitoring. After-
wards, the US-CT fusion was performed, on which the
prostate volume was delineated and used as a reference
for weekly US imaging in the treatment room.
Autoscan probe
The autoscan-US probe consists of a one dimensional
(1D) transducer array of 128 elements, using a central
frequency of 5.0 MHz. The probe is provided with IR
reflectors fixed in a way that can be detected by the
ceiling mounted IR-camera. Initially, the probe is affixed
to a TPUS kit, placed over the coach under the patients’
knees, and pushed gently to the patient for scanning.
The motorized head is capable of real-time online
scanning of the prostate.
Prostate monitoring in the treatment room
The patient was prepared for daily treatment by aligning
him to the lasers guided by reference marks (tattoos) on
the skin, ie to reproduce the patient’s setup position
from the CT-simulation room. Prior to treatment, the
inter-fraction patient positioning was corrected for by
daily kV images by utilizing three implanted FMs. Once
a week and immediately after treatment delivery the
TPUS monitoring system was set up for real-time
tracking of the prostate. The time dependent prostate
displacements (prostate intrafractional motion) were
recorded in 2 to 2.5 min. For each patient, 4–6 US scans
were acquired. The prostate displacements in the three
orthogonal directions were recorded for retrospective
analysis.
Statistical analysis
The prostate data, showing real-time prostate COM
position in the Inferior-Superior (I/S), Left-Right (L/R)
and Anterior-Posterior (A/P) directions, were evaluated
using the Clarity workstation by one observer (MB). For
some fractions, irregular fluctuating data at the beginning
of the monitoring curve were discarded. The maximum
prostate displacement in each direction was recorded for
each fraction. Furthermore, the Euclidean distance (3D
vector) was computed and the maximal 3D vector was
recorded for each fraction. Finally, the mean (±1 standard
deviation (SD)) of the maximal displacements in each
direction and for the 3D vector were calculated. The BMI
value for each patient was calculated to investigate corre-
lation between magnitudes of the displacement against
the BMI. For the data and statistical analysis the statistical
program R (version 2.15.3) was used.
Results
All the patients enrolled in this study were cooperative,
despite the extra time of about 10 min for each fraction
needed for the autoscan setup and prostate monitoring.
None of the patients expressed any discomfort during
the autoscan setup, nor from the TPUS real-time scanning.
Data analysis of the 51 TPUS scans resulted in mean
values (±1SD) of the maximal intrafractional displace-
ments of the prostate [mm]; I(+)/S: (0.2 ± 0.9); L(+)/R:
(−0.2 ± 0.8); and A(+)/P: (−0.2 ± 1.1). The largest dis-
placement was 2.8 mm in the posterior direction. The
percentage of fractions larger than 2.0 mm was 4 %, 2 %,
and 10 % in the IS, LR, and AP directions, respectively.
The mean Euclidean distance of the 51 scans was 0.9 ±
0.6 mm. The percentage of fractions with 3D vector
displacement larger than 2.0 mm was 12 %, and only 2
scans (4 %) showed displacements larger than 3.0 mm.
No correlation was found between BMI-value and the
magnitude of the prostate displacement.
The monitoring curves of the prostate show variations
in prostate displacement between different fractions
(Fig. 1). A common zero point, start point for the curves,
was established by choosing an arbitrary position-value
for each scan/curve, a position immediately after the
prostate tracking initiated, and then subtracting that value
from the rest. For some fractions, the tendency of larger
intrafractional displacement for prolonged observation
times can be observed. The figure also indicates that the
extent of the prostate intrafractional displacement has its
largest dispersal in the A/P direction, and least displace-
ments in the L/R direction.
Figure 2a-c presents boxplots of the maximal displace-
ments at each fraction for each of the ten patients in I/S,
L/R, and A/P directions, respectively. The horizontal
band inside the box indicates the second quartile
(median), the lower and the upper edges of the box
indicate the first (25th) and third (75th) quartiles. Fur-
thermore, the lower and the upper extremes of the
whiskers display the minimum and maximum values in
the absence of single data point outliers. The individual
boxplot of maximal prostate displacements is based on
analysis of 4–6 TPUS scans per patient. As can be
observed, there are some variations in prostate displace-
ments between the patients and in the different directions.
The overall maximal prostate displacement in all three
directions and the Euclidean 3D vector were shown to be
less than 2.0 mm for most of the fractions (Fig. 2d).
Discussion
Intrafractional prostate motion has been investigated
previously using pre- and post-treatment imaging. One
weakness in applying this method is inter-observer
matching uncertainty [24]. Despite matching variability,
using portal imaging of seeds, there is an additional
error associated with the thickness of the CT-slices that
may introduce further uncertainty into the determin-
ation of the displacement. Another drawback is that the
prostate can be displaced and then revert to its initial
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Fig. 1 Intrafractional prostate displacement; (a-c) Monitoring graphs show the prostate motion for the total 51 US scans in I/S, L/R, and A/P
directions, (d) The 3D vector displacement of the prostate center of mass
Fig. 2 Boxplots of the intrafractional prostate displacements; (a-c) Boxplots of the prostate displacements for ten patients in I/S, L/R, and A/P
directions. (d) Boxplot of overall prostate displacements in I/S, L/R, and A/P directions, including Euclidean (3D vector) distance
Baker and Behrens BMC Cancer  (2016) 16:484 Page 4 of 7
position, as can be observed in Fig. 1, which cannot be
detected by only a single snapshot pre- and post-
treatment image [25]. Therefore real-time tracking is a
proper monitoring method to accurately detect intra-
fractional prostate motion. Table 2 tabulates the results
of the present study and previously reported data.
In this study the 4D TPUS monitoring system was
shown to be able to track the prostate. The 4D autoscan
probe have previously been applied as a reliable tool to
measure the prostate displacement during transabdo-
minal probe simulation [26]. The operators, with expe-
rience from frequently used transabdominal scanning,
reported that using the TPUS system, it was easier to
acquire images and identify soft tissue structures com-
pared to transabdominal scanning. In a previous phantom
study, Abramowitz et al. found good agreement between
the TPUS autoscan and Calypso system (Varian Medical
Systems, Palo Alto, CA) in tracking the embedded
prostate-like sphere [27]. The Calypso system has been
investigated in different studies, which have confirmed
that it is an accurate monitoring method for tracking the
prostate gland.
In the current study, prostate monitoring was limited
to approximately 2.5 min, a typical beam-on time to
deliver a RapidArc fraction. We observed that the pros-
tate is not stationary during the tracking time, and
displacements tend to increases with the elapsed
monitoring time, which is in line with the findings of
other published papers [20]. Ballhausen et al. found that
the intrafractional motion of the prostate tends to “a lin-
ear increase of the variance” with the duration of the
fraction. Furthermore, we found that the displacement
varies for different fractions and also for different
patients.
In our study, we noticed that, for most of the fractions,
the intrafractional prostate motion was mostly smaller
than 2 mm, for a period of 2 to 2.5 min. Comparably,
Choi et al. [28], using transrectal ultrasound scans to
track three implanted fiducial markers (12 patients and
336 fractions), observed that only 11 % of the 3D vector
displacements were larger than 2 mm during 4–5 min of
monitoring (Table 2). Similarly, Li et al. [4], utilizing a
Calypso tracking system (35 patients and 1267 fractions),
reported that the intrafractional motion of the prostate
is mostly less than 2 mm, especially for the first three
minutes of tracking. They concluded that a CTV-PTV
margin of 2 mm is adequate to ensure covering the
target with the planned prescribed dose, despite larger
intrafractional uncertainty for some of the patients.
Furthermore, Vargas et al. [29], in an Cine-MRI study,
calculated the CTV-PTV margin to be 2.1 mm, compa-
rable to Li et al.’s, which would account for the intra-
fractional motion. They showed also that the prostate
motion is smaller in supine than prone patient
Table 2 Intrafraction prostate motion in three directions and 3D vector; a comparison of the present study with previously
published data using different systems
Mean of max prostate shifts
(±1SD) [mm]
Investigator, year N (fractions) System Time [min] I(+)/S L(+)/R A(+)/P % 3D vector shift 3D-vector [mm]
Lometti et al., 2005 [33] 11 (133) MV fluoroscopy: real-time FM
tracking
1 >2 mm 4 % 0.7 ± 0.5
Li HS et al., 2008 [4] 35 (1267) Calypso 12 0.3 ± 0.7 0.0 ± 0.3 0.4 ± 0.6
Kupelian et al., 2008 [2] 17 (550) Calypso 10 >3 mm 14 %
Langen et al., 2008 [18] 17 (550) Calypso 2 >3 mm 3 %
Li et al., 2009 [19] 20 (157) Calypso 11.4 >3 mm 19 %
Vargas et al., 2010 [29] 7 (68) Cine-MRI 4 0.41 ± 1.2
Wang et al., 2011 [34] 29 (1061) Calypso 3 >3 mm 9 %
Smeenk et al., 2011
[30]
15 (576) Calypso 2.5 >3 mm 1.4 %
Ng et al., 2012 [32] 10 (268) Real-time kilovoltage FM
tracking
3–4 >3 mm 5.6 %
Mayyas et al., 2013 [9] 8 Pre- post-treatment kV
images
0.8 ± 2.7 0.2. ± 2.1 −0.3 ± 2.4
Mayyas et al., 2013 [9] 19 Calypso 0.0 ± 1.5 0.0 ± 0.6 0.0 ± 1.3
Tong et al., 2015 [8] 236 (8660) Calypso 2 >2 mm 13 %
Choi et al., 2015 [28] 12 (336) Transrectal US/3 FMs 4–5 0.6 ± 0.6 −0.3 ± 0.3 −0.7 ± 0.6 >2 mm 11 % 1.1 ± 0.8
Present study 10 (51) Clarity real-time TPUS 2–2.5 0.2 ± 0.9 −0.2 ± 0.8 −0.2 ± 1.1 >2 mm 12 % 0.9 ± 0.6
Intrafractional motion of prostate patients (N) in 3D vector, I/S, inferior-superior, L/R, left-right, and A/P, anterior-posterior directions, using TPUS, transperineal
Clarity ultrasound (US) system, Calypso system, implanted fiducial markers (FMs), CINE-MRI, and endorectal balloon
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positioning. On the other hand, Smeenk et al. [30], again
using Calypso system (15 patients and 576 fractions),
discovered that prostate motion in 3D vector was larger
than 3 mm in only 1.4 % of the fractions during the first
2.5 min, but increased to 18 % for a monitoring duration
of 10 min. Comparably, Tong et al. [8], also using Calypso
tracking system (236 patients and 8660 fractions), showed
that up to 20 % of the prostate shift can be larger than
3 mm when tracking time is 12 min. But they ascertained
that the prostate motion, for the first three minutes, is
very small (<2 mm) for most patients. Similarly, Shelton et
al. [31] investigated the intrafraction prostate motion,
once again using Calypso system (37 patients and 1332
fractions), and found that the overall mean value of the
3D vector displacement is less than 3 mm for the first
3 min, but increased with duration time to up to 6.5 mm
in the fourteenth minute. Likewise, Kupelian et al. [2],
once more using Calypso system (17 patients and 550
fractions) detected that during 10 min monitoring in 14 %
of the fractions the shift was larger than 3 mm. Further-
more, Ng et al. [32], in a study of real-time FM tracking,
observed that in 62 % of the fractions (10 patients, 268
fractions) the 3D vector displacement of the prostate,
during 3–4 min tracking was smaller than 1 mm, and
corresponded values were 95 %, 82 %, and 80 % in the LR,
IS, and AP directions, respectively. They discovered that
only 6 % of the shifts were larger than 3 mm. More-
over, Langen et al. [18], as well using Calypso system (17
patients and 550 fractions), spotted that only 3 % of
the shift is larger than 3 mm while tracking the pros-
tate for about 2 min. In addition, Lometti et al. [33],
using MV fluoroscopy; real-time FM tracking (11 patients
and 133 fractions), confirmed that in only 4 % of the
fractions the displacement is larger than 2 mm while
tracking for only one minute. Last, Mayyas et al. [9], in a
comparison study of four different systems (27 patients
and 1100 fractions), found that the percentage of intrafrac-
tional shifts within ±1.5 mm was 76 %, 94 %, and 82 % in
the I/S, L/R, and A/P directions. In summary, the published
evidence in combination with this study justifies the asser-
tion that the intrafractional motion of the prostate is insig-
nificant during the first 2.5 min, thus not of clinical
consequence while employing advanced VMAT/ RapidArc.
As all other studies, there are limiting factors in the
current study; Firstly, the study does not reveal the
magnitude of the intrafractional prostate rotation or form
deformation. Second, the number of patients and fractions
are limited. Third, a dosimetric study is necessary to in-
vestigate the impact of the larger prostate displacements
on the clinical treatment outcome of the treatment.
Conclusion
Intrafractional prostate displacement varies between
fractions and for different patients. The displacement is
insignificant for the first 2–2.5 min of the monitoring
time, but increases with elapsed time. Consequently,
prostate shifts during conventional and IMRT treatment
delivery should be taken into consideration, but are clini-
cally inconsequential while employing advanced VMAT/
RapidArc techniques.
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